Constitution Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$277K Hold
765
0.14% 56
2026
Q1
$269K Hold
765
0.13% 52
2025
Q4
$250K Sell
765
-400
-34% -$127K 0.12% 57
2025
Q3
$329K Buy
1,165
+400
+52% +$116K 0.15% 51
2025
Q2
$214K Hold
765
0.11% 56
2025
Q1
$238K Buy
+765
New +$226K 0.13% 55
2024
Q4
Sell
-765
Closed -$246K 57
2024
Q3
$246K Hold
765
0.13% 55
2024
Q2
$239K Hold
765
0.13% 61
2024
Q1
$218K Buy
+765
New +$224K 0.12% 59
2023
Q1
Sell
-865
Closed -$227K 68
2022
Q4
$227K Buy
+865
New +$232K 0.14% 62
2022
Q3
Sell
-865
Closed -$210K 64
2022
Q2
$210K Hold
865
0.13% 57
2022
Q1
$209K Buy
+865
New +$199K 0.11% 64
2021
Q4
Sell
-1,065
Closed -$226K 66
2021
Q3
$226K Buy
+1,065
New +$245K 0.14% 61

Other funds holding AMGN

Constitution Capital's AMGN Position: Q2 2026 in Review

Constitution Capital held its Amgen (AMGN) position steady in Q2 2026 at 765 shares worth $277K. The position accounts for 0.14% of the portfolio, ranked #56.

Constitution Capital first reported a position in AMGN in Q3 2021 and has held it in 13 quarters since. The position peaked at $329K in Q3 2025. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Constitution Capital held 765 shares of Amgen worth $277K as of Q2 2026.
  • Constitution Capital left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.14% of Constitution Capital's portfolio in Q2 2026, its #56 holding.
  • Constitution Capital first reported a position in Amgen in Q3 2021 and has held it in 13 quarters since.
  • Constitution Capital's Amgen position peaked at $329K in Q3 2025.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Constitution Capital's 13F filing for Q2 2026, filed 9 Jul 2026.